A Curated Platform of Equity & Options Market Intelligence
Select Page

ABBV

Search by
TICKER SYMBOL

Abbvie Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

143.41

1.02

(0.716%)

Volume:

4,903,432

52 week range:

128.24 - 162.75

Market Cap:

253.196B

Company Description:

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.